- Home
- GPRK vs CMPX Comparison
GPRK vs CMPX Comparison
Compare GPRK & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPRK
- CMPX
- Stock Information
- Founded
- GPRK 2002
- CMPX 2014
- Country
- GPRK Colombia
- CMPX United States
- Employees
- GPRK N/A
- CMPX N/A
- Industry
- GPRK Oil & Gas Production
- CMPX Biotechnology: Pharmaceutical Preparations
- Sector
- GPRK Energy
- CMPX Health Care
- Exchange
- GPRK Nasdaq
- CMPX Nasdaq
- Market Cap
- GPRK 335.7M
- CMPX 291.8M
- IPO Year
- GPRK N/A
- CMPX N/A
- Fundamental
- Price
- GPRK $6.35
- CMPX $3.44
- Analyst Decision
- GPRK Buy
- CMPX Strong Buy
- Analyst Count
- GPRK 1
- CMPX 8
- Target Price
- GPRK $11.00
- CMPX $13.50
- AVG Volume (30 Days)
- GPRK 704.3K
- CMPX 1.4M
- Earning Date
- GPRK 11-05-2025
- CMPX 08-11-2025
- Dividend Yield
- GPRK 9.29%
- CMPX N/A
- EPS Growth
- GPRK N/A
- CMPX N/A
- EPS
- GPRK 0.81
- CMPX N/A
- Revenue
- GPRK $560,354,000.00
- CMPX N/A
- Revenue This Year
- GPRK N/A
- CMPX N/A
- Revenue Next Year
- GPRK N/A
- CMPX N/A
- P/E Ratio
- GPRK $7.85
- CMPX N/A
- Revenue Growth
- GPRK N/A
- CMPX N/A
- 52 Week Low
- GPRK $5.66
- CMPX $1.27
- 52 Week High
- GPRK $11.72
- CMPX $4.08
- Technical
- Relative Strength Index (RSI)
- GPRK 45.00
- CMPX 62.85
- Support Level
- GPRK $6.18
- CMPX $3.29
- Resistance Level
- GPRK $6.69
- CMPX $3.52
- Average True Range (ATR)
- GPRK 0.23
- CMPX 0.18
- MACD
- GPRK 0.00
- CMPX 0.04
- Stochastic Oscillator
- GPRK 30.00
- CMPX 81.68
About GPRK Geopark Ltd
GeoPark Ltd is a Latin American oil and gas exploration and production company with assets in Colombia, Ecuador, Chile, Brazil, and Argentina. The company generates revenue from the sale of crude oil, condensate, and natural gas, net of value-added tax and discounts related to the sale and overriding royalties due to the ex-owners of oil and gas properties where the royalty arrangements represent a retained working interest in the property.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.